Biofilms—the eradication has begun
Have you ever heard of biofilms? They are slimy, glue-like membranes that are produced by microbes, like bacteria and fungi, in order to...
The MUHC Foundation launches a $10-million fundraising campaign for research
More than 150 guests joined the McGill University Health Centre (MUHC) Foundation to celebrate the achievements of two Montreal...
Kidney graft success - does age and sex matter?
The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published...
On the genetics trail
Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...
Encouraging results for patients with aggressive brain cancer
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...
A prescription with legs!
A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...
What is high Lipoprotein(a), and should I be concerned?
A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...
New marker and potential therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...
A surprise advance in the treatment of adult cancers
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...
New marker identified for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...